Publisher Full Text
[Role and regulation of dopamine D1 receptors in the striatum: implications for the genesis of dyskinesia in Parkinson's disease].Rev Neurol (Paris). 2006 Jun; 162(6-7):691-702.RN
Abstract
L-dopa treatment of Parkinson's disease is complicated in the long term by the appearance of dyskinesia. Hypersensitivity of D1 dopamine receptor has been suggested to play a role in these delayed adverse effects. Hypersensitivity of dopamine D1 receptor in Parkinson's disease can be accounted for by increased levels of Galphaolf, the stimulatory G protein which couples D1 receptor to adenylyl cyclase in the striatum. We here discuss the possible role of D1 receptor signal transduction in the genesis of L-dopa-induced dyskinesia in the light of Galphaolf regulation.
Links
MeSH
Pub Type(s)
English Abstract
Journal Article
Review
Language
fre
PubMed ID
16840977
Citation
Corvol, J-C, et al. "[Role and Regulation of Dopamine D1 Receptors in the Striatum: Implications for the Genesis of Dyskinesia in Parkinson's Disease]." Revue Neurologique, vol. 162, no. 6-7, 2006, pp. 691-702.
Corvol JC, Girault JA, Hervé D. [Role and regulation of dopamine D1 receptors in the striatum: implications for the genesis of dyskinesia in Parkinson's disease]. Rev Neurol (Paris). 2006;162(6-7):691-702.
Corvol, J. C., Girault, J. A., & Hervé, D. (2006). [Role and regulation of dopamine D1 receptors in the striatum: implications for the genesis of dyskinesia in Parkinson's disease]. Revue Neurologique, 162(6-7), 691-702.
Corvol JC, Girault JA, Hervé D. [Role and Regulation of Dopamine D1 Receptors in the Striatum: Implications for the Genesis of Dyskinesia in Parkinson's Disease]. Rev Neurol (Paris). 2006;162(6-7):691-702. PubMed PMID: 16840977.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Role and regulation of dopamine D1 receptors in the striatum: implications for the genesis of dyskinesia in Parkinson's disease].
AU - Corvol,J-C,
AU - Girault,J-A,
AU - Hervé,D,
PY - 2006/7/15/pubmed
PY - 2006/11/10/medline
PY - 2006/7/15/entrez
SP - 691
EP - 702
JF - Revue neurologique
JO - Rev Neurol (Paris)
VL - 162
IS - 6-7
N2 - L-dopa treatment of Parkinson's disease is complicated in the long term by the appearance of dyskinesia. Hypersensitivity of D1 dopamine receptor has been suggested to play a role in these delayed adverse effects. Hypersensitivity of dopamine D1 receptor in Parkinson's disease can be accounted for by increased levels of Galphaolf, the stimulatory G protein which couples D1 receptor to adenylyl cyclase in the striatum. We here discuss the possible role of D1 receptor signal transduction in the genesis of L-dopa-induced dyskinesia in the light of Galphaolf regulation.
SN - 0035-3787
UR - https://www.unboundmedicine.com/medline/citation/16840977/[Role_and_regulation_of_dopamine_D1_receptors_in_the_striatum:_implications_for_the_genesis_of_dyskinesia_in_Parkinson's_disease]_
L2 - https://linkinghub.elsevier.com/retrieve/pii/MDOI-RN-06-2006-162-6-7-0035-3787-101019-200601067
DB - PRIME
DP - Unbound Medicine
ER -